Literature DB >> 20075974

Retinal vasoproliferative tumours.

I G Rennie1.   

Abstract

Vasoproliferative tumours are uncommon retinal lesions that may occur in isolation (primary) or in association with another ocular condition (secondary). They may be unilateral or bilateral and have a predilection for the peripheral inferior temporal quadrant of the retina. Vasoproliferative tumours can be associated with abnormalities of the macular, including epiretinal membrane formation and cystoid macular edema. A number of modalities have been used to treat these tumours including cryotherapy and radiotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 20075974     DOI: 10.1038/eye.2009.305

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

1.  Macular sequelae in vasoproliferative tumors: results of surgical approach.

Authors:  Asterios Diafas; Victoria Toumanidou; Ioannis Kassos; Maria Samouilidou; Anna Dastiridou; Nikolaos Ziakas; Sofia Androudi
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

2.  Intravitreal bevacizumab in the treatment of vasoproliferative retinal tumours.

Authors:  C Rogers; B Damato; I Kumar; H Heimann
Journal:  Eye (Lond)       Date:  2014-05-30       Impact factor: 3.775

3.  Intravitreal bevacizumab role in the treatment of macular edema secondary to retinal vasoproliferative tumor in a patient with neurofibromatosis type 1.

Authors:  Ramin Nourinia; Tahmineh Motevasseli; Zahra Tofighi
Journal:  GMS Ophthalmol Cases       Date:  2016-09-02

4.  Indocyanine green angiographic findings in seven eyes with vasoproliferative retinal tumor.

Authors:  Saya Matsuura; Tomoka Ishida; Miho Tobe; Minami Uchida; Ryoko Souma; Kyoko Ohno-Matsui
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-16

5.  Management of Vasoproliferative Tumors of the Retina with Macular Complications by Pars Plana Vitrectomy Combined with Episcleral Cryotherapy.

Authors:  Wenhua Zhang; Zeyuan Qiang; Hao Song; Xiaoli Li; Handong Dan; Keke Ge; Pan Li; Zixu Huang; Dongdong Wang; Feng Chen; Bin Zheng; Zongming Song
Journal:  J Ophthalmol       Date:  2021-04-13       Impact factor: 1.909

6.  Emerging roles for antiangiogenesis factors in management of ocular disease.

Authors:  Muhammad Usman Saeed; Evangelia Gkaragkani; Kashif Ali
Journal:  Clin Ophthalmol       Date:  2013-03-13

7.  A novel mutation in the NR2E3 gene associated with Goldmann-Favre syndrome and vasoproliferative tumor of the retina.

Authors:  George J Manayath; Prasanthi Namburi; Sundaresan Periasamy; Jeevan A Kale; Venkatapathy Narendran; Anuradha Ganesh
Journal:  Mol Vis       Date:  2014-05-29       Impact factor: 2.367

8.  Clinical features and treatment outcomes of vasoproliferative tumors in Indian participants.

Authors:  Jaydeep Avinash Walinjkar; Unnati Shivshankar Sharma; Pukhraj Rishi; Ekta Rishi; Lingam Gopal; Tarun Sharma
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

9.  Retinal meteor.

Authors:  Ramesh Venkatesh; Prachi Gurav; Prachi Abhishek Dave; Sankhadeep Roy
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

10.  Updated Systematic Review and Clinical Spectrum of Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Abdulrahman H Badawi; Valmore A Semidey; Moustafa Magliyah; Hassan Al-Dhibi
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.